Literature DB >> 18806489

Merkel cell carcinoma in situ arising in a trichilemmal cyst: a case report and literature review.

Wei Su1, Sonia M Kheir, Brenda Berberian, Clay J Cockerell.   

Abstract

A 73-year-old man presented with a 4-mm asymptomatic, smooth, dome-shaped lesion on the right fourth finger with a clinical impression of a cyst/dermatofibroma. Histological examination showed a trichilemmal cyst with 3 nests of small blue round cells within the basal layer of the cyst lining. There were many mitotic figures and apoptotic bodies. The stain for cytokeratin 20 "decorated" the tumor cells with an unequivocal perinuclear dot-like pattern, confirming their Merkel cell origin. Dermal Merkel cell carcinoma (MCC) arising in association with benign adnexal tumors or cysts, with or without epithelial involvement, is a rare event. MCC in situ in this context has not been previously reported. The immunostain for cytokeratin 20 is an important ancillary study in diagnosing MCC. Our case supports the view that a subset of MCCs is of intraepithelial origin and underscores the clinical importance of surveillance for changes in an "innocent" cyst.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806489     DOI: 10.1097/DAD.0b013e31817a9896

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Evolving paradigm in treatment of Merkel cell carcinoma of the digit from ray resection to wide local excision and flap coverage.

Authors:  Alex J Doermann; James G Jakowatz; Neil F Jones
Journal:  Hand (N Y)       Date:  2015-04-07

2.  [Perforating and ruptured trichilemmal cyst with metaplastic ossification].

Authors:  M Bär; D M Kayser; M Trniková; N Grunow
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

Review 3.  [Merkel cell carcinoma of the eyelid. An often unrecognized tumor entity : Clinical aspects and treatment strategies].

Authors:  R Hoerster; M Schlaak; K R Koch; M Ortmann; C Mauch; L M Heindl
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.